Chandan Healthcare Limited Launches Diagnostic Centre in Raipur, Enters Chhattisgarh Market
Lucknow, India – March 27, 2026 – Chandan Healthcare Limited (NSE - CHANDAN) has expanded its operations with the launch of a new diagnostic centre in Raipur, Chhattisgarh, marking the company’s entry into the state.The Raipur centre provides comprehensive diagnostic services, including pathology and blood investigations, alongside advanced tests such as TMT, ECG, EEG, and PFT. The facility also includes provisions for CT and MRI services and is designed to cater to a wide range of patient needs while supporting diagnostic requirements of partner centres within the network.
According to Amar Singh, Promoter and Managing Director of Chandan Healthcare Limited, the expansion aligns with the company’s strategy to build a scalable and integrated diagnostic network.
Chandan Healthcare Limited, established in 2003, is a diagnostics company based in North India and part of the Chandan Group. The company has a presence across Uttar Pradesh, Uttarakhand, Rajasthan, Bihar, Madhya Pradesh, and Delhi, operating 60+ diagnostic centres and over 360 collection centres.
Key Strengths and Financial Performance
In fiscal year 2025, Chandan Healthcare Limited achieved ₹230.12 crore in revenue, ₹43.38 crore in EBITDA, and ₹22.17 crore in profit.
Growth Strategy
The company is expanding its footprint across several states and is utilizing Chandan Medical Centres (CMCs) to penetrate new markets. Chandan Healthcare Limited was listed on NSE Emerge on February 17, 2025.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.